Enrollment in the 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer Inc and German partner BioNTech is more than 50 percent complete, Dr. Nicholas Kitchin, a top Pfizer vaccine research and development scientist, said at the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices meeting on Wednesday.
FILE PHOTO: A sign is pictured outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020. REUTERS/Carlo Allegri
NEW YORK - Enrollment in the 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer Inc and German partner BioNTech is more than 50 percent complete, Dr. Nicholas Kitchin, a top Pfizer vaccine research and development scientist, said at the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices meeting on Wednesday.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
‘It’s been Covid, Covid, Covid’: Pro-Trump super PAC plans ad blitz on the economyAmericans are still grappling with a global pandemic that has claimed nearly 180,000 lives in the U.S. alone. But America First Action, the largest super PAC supporting President Donald Trump’s reelection, is about to go all-in on the economy.
Weiterlesen »
Coronavirus: AstraZeneca starts trial of COVID-19 antibody treatmentBritish drugmaker AstraZeneca has started early testing of an antibody-based treatment for the prevention and treatment of COVID-19, the company said on Tuesday.
Weiterlesen »
AstraZeneca starts trial of COVID-19 antibody treatmentBritish drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
Weiterlesen »
How L.A. doctors plan to include more people of color in COVID-19 vaccine trialDoctors at Harbor-UCLA are participating in a COVID-19 vaccine trial, and they're aiming to recruit people of color and members of other high-risk groups.
Weiterlesen »
Could U.S. regulators authorize a COVID-19 vaccine before the election?U.S. President Donald Trump has said a vaccine for the novel coronavirus could be available before the Nov. 3 presidential election, sooner than most experts anticipate.
Weiterlesen »
'Disaster inside a disaster': California wildfires and COVID-19 form twin crisesThe California LNU Lightning Complex fire has claimed the lives of at least 5 people, burned more than 350K acres and forced thousands to flee their homes.
Weiterlesen »